These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 28770641

  • 41. Epidemiology of HIV infection in women and children: a global perspective.
    Shetty AK.
    Curr HIV Res; 2013 Mar; 11(2):81-92. PubMed ID: 23432485
    [Abstract] [Full Text] [Related]

  • 42. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.
    Samuel R, Paredes R, Parboosing R, Moodley P, Gordon M.
    AIDS Rev; 2014 Mar; 16(4):187-98. PubMed ID: 25300623
    [Abstract] [Full Text] [Related]

  • 43. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N.
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [Abstract] [Full Text] [Related]

  • 44. Shifting to the long view: engagement of pregnant and postpartum women living with HIV in lifelong antiretroviral therapy services.
    Phillips TK, Myer L.
    Expert Rev Anti Infect Ther; 2019 May; 17(5):349-361. PubMed ID: 30978126
    [Abstract] [Full Text] [Related]

  • 45. The cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.
    Yu W, Li C, Fu X, Cui Z, Liu X, Fan L, Zhang G, Ma J.
    PLoS One; 2014 May; 9(7):e102872. PubMed ID: 25055039
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Cost-effectiveness of option B+ in prevention of mother-to-child transmission of HIV in Yunnan Province, China.
    Wang X, Guo G, Zheng J, Lu L.
    BMC Infect Dis; 2019 Jun 11; 19(1):517. PubMed ID: 31185927
    [Abstract] [Full Text] [Related]

  • 48. Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.
    Colombini M, Stöckl H, Watts C, Zimmerman C, Agamasu E, Mayhew SH.
    AIDS Care; 2014 Jun 11; 26(7):914-26. PubMed ID: 24354642
    [Abstract] [Full Text] [Related]

  • 49. The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV.
    O'Brien L, Shaffer N, Sangrujee N, Abimbola TO.
    Bull World Health Organ; 2014 Mar 01; 92(3):162-70. PubMed ID: 24700975
    [Abstract] [Full Text] [Related]

  • 50. The impact of approaches in improving male partner involvement in the prevention of mother-to-child transmission of HIV on the uptake of maternal antiretroviral therapy among HIV-seropositive pregnant women in sub-Saharan Africa: a systematic review and meta-analysis.
    Takah NF, Kennedy ITR, Johnman C.
    BMJ Open; 2017 Nov 25; 7(11):e018207. PubMed ID: 29175889
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?
    Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y.
    Am J Obstet Gynecol; 2015 Sep 25; 213(3):341.e1-12. PubMed ID: 25979615
    [Abstract] [Full Text] [Related]

  • 53. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
    Fatti G, Shaikh N, Eley B, Grimwood A.
    AIDS Care; 2016 Sep 25; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
    [Abstract] [Full Text] [Related]

  • 54. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS, Read JS.
    Expert Opin Pharmacother; 2011 Aug 25; 12(12):1875-85. PubMed ID: 21534886
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.
    Westreich D, Eron J, Behets F, Horst Cv, Van Rie A.
    J Infect Dis; 2007 Mar 15; 195(6):837-46. PubMed ID: 17299714
    [Abstract] [Full Text] [Related]

  • 58. Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic model.
    Gamell A, Luwanda LB, Kalinjuma AV, Samson L, Ntamatungiro AJ, Weisser M, Gingo W, Tanner M, Hatz C, Letang E, Battegay M, KIULARCO Study Group.
    PLoS One; 2017 Mar 15; 12(7):e0181096. PubMed ID: 28704472
    [Abstract] [Full Text] [Related]

  • 59. Moving toward test and start: learning from the experience of universal antiretroviral therapy programs for HIV-infected pregnant/ breastfeeding women.
    Forhan SE, Modi S, Houston JC, Broyles LN.
    AIDS; 2017 Jun 19; 31(10):1489-1493. PubMed ID: 28574966
    [Abstract] [Full Text] [Related]

  • 60. Adherence to option B + antiretroviral therapy and associated factors in pregnant and breastfeeding women in Sub-Saharan Africa: a systematic review and meta-analysis.
    Fassinou LC, Songwa Nkeunang D, Delvaux T, Nagot N, Kirakoya-Samadoulougou F.
    BMC Public Health; 2024 Jan 05; 24(1):94. PubMed ID: 38183014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.